Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sophie Dahoun is active.

Publication


Featured researches published by Sophie Dahoun.


European Journal of Human Genetics | 2009

Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21

Robert Lyle; Frédérique Béna; Sarantis Gagos; Corinne Gehrig; Gipsy Lopez; Albert Schinzel; James Lespinasse; Armand Bottani; Sophie Dahoun; Laurence Taine; Martine Doco-Fenzy; Pascale Cornillet-Lefebvre; Anna Pelet; Stanislas Lyonnet; Annick Toutain; Laurence Colleaux; Jürgen Horst; Ingo Kennerknecht; Nobuaki Wakamatsu; Maria Descartes; Judy Franklin; Lina Florentin-Arar; Sophia Kitsiou; Emilie Aı̈t Yahya-Graison; Maher Costantine; Pierre-Marie Sinet; Jean Maurice Delabar

Down syndrome (DS) is one of the most frequent congenital birth defects, and the most common genetic cause of mental retardation. In most cases, DS results from the presence of an extra copy of chromosome 21. DS has a complex phenotype, and a major goal of DS research is to identify genotype–phenotype correlations. Cases of partial trisomy 21 and other HSA21 rearrangements associated with DS features could identify genomic regions associated with specific phenotypes. We have developed a BAC array spanning HSA21q and used array comparative genome hybridization (aCGH) to enable high-resolution mapping of pathogenic partial aneuploidies and unbalanced translocations involving HSA21. We report the identification and mapping of 30 pathogenic chromosomal aberrations of HSA21 consisting of 19 partial trisomies and 11 partial monosomies for different segments of HSA21. The breakpoints have been mapped to within ∼85 kb. The majority of the breakpoints (26 of 30) for the partial aneuploidies map within a 10-Mb region. Our data argue against a single DS critical region. We identify susceptibility regions for 25 phenotypes for DS and 27 regions for monosomy 21. However, most of these regions are still broad, and more cases are needed to narrow down the phenotypic maps to a reasonable number of candidate genomic elements per phenotype.


Genetics in Medicine | 2011

Consanguineous marriages, pearls and perils: Geneva International Consanguinity Workshop Report.

Hanan Hamamy; Luigi Luca Cavalli-Sforza; Samia A. Temtamy; Giovanni Romeo; Leo P. ten Kate; Robin L. Bennett; Alison Shaw; André Mégarbané; Cornelia van Duijn; Heli Bathija; Siv Fokstuen; Eric Engel; Joël Zlotogora; Emmanouil T. Dermitzakis; Armand Bottani; Sophie Dahoun; Michael A. Morris; Steve Arsenault; Mona Aglan; Mubasshir Ajaz; Ayad Alkalamchi; Dhekra Alnaqeb; Mohamed K Alwasiyah; Nawfal Anwer; Rawan Awwad; Melissa Bonnefin; Peter Corry; Lorraine Gwanmesia; Gulshan Karbani; Maryam Mostafavi

Approximately 1.1 billion people currently live in countries where consanguineous marriages are customary, and among them one in every three marriages is between cousins. Opinions diverge between those warning of the possible health risks to offspring and others who highlight the social benefits of consanguineous marriages. A consanguinity study group of international experts and counselors met at the Geneva International Consanguinity Workshop from May 3 2010, to May 7, 2010, to discuss the known and presumptive risks and benefits of close kin marriages and to identify important future areas for research on consanguinity. The group highlighted the importance of evidence-based counseling recommendations for consanguineous marriages and of undertaking both genomic and social research in defining the various influences and outcomes of consanguinity. Technological advances in rapid high-throughput genome sequencing and for the identification of copy number variants by comparative genomic hybridization offer a significant opportunity to identify genotype-phenotype correlations focusing on autozygosity, the hallmark of consanguinity. The ongoing strong preferential culture of close kin marriages in many societies, and among migrant communities in Western countries, merits an equivalently detailed assessment of the social and genetic benefits of consanguinity in future studies.


Embo Molecular Medicine | 2013

Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21

Youssef Hibaoui; Iwona Grad; A. Letourneau; M. Reza Sailani; Sophie Dahoun; Federico Santoni; Stefania Gimelli; Michel Guipponi; Marie Françoise Pelte; Frédérique Béna; Anis Feki

Down syndrome (trisomy 21) is the most common viable chromosomal disorder with intellectual impairment and several other developmental abnormalities. Here, we report the generation and characterization of induced pluripotent stem cells (iPSCs) derived from monozygotic twins discordant for trisomy 21 in order to eliminate the effects of the variability of genomic background. The alterations observed by genetic analysis at the iPSC level and at first approximation in early development illustrate the developmental disease transcriptional signature of Down syndrome. Moreover, we observed an abnormal neural differentiation of Down syndrome iPSCs in vivo when formed teratoma in NOD‐SCID mice, and in vitro when differentiated into neuroprogenitors and neurons. These defects were associated with changes in the architecture and density of neurons, astroglial and oligodendroglial cells together with misexpression of genes involved in neurogenesis, lineage specification and differentiation. Furthermore, we provide novel evidence that dual‐specificity tyrosine‐(Y)‐phosphorylation regulated kinase 1A (DYRK1A) on chromosome 21 likely contributes to these defects. Importantly, we found that targeting DYRK1A pharmacologically or by shRNA results in a considerable correction of these defects.


European Journal of Human Genetics | 2004

An excess of chromosome 1 breakpoints in male infertility.

Iben Bache; Elvire Van Assche; Sultan Cingöz; Merete Bugge; Zeynep Tümer; Mads F. Hjorth; Claes Lundsteen; James Lespinasse; Kirsten Winther; Anita Niebuhr; Vera M. Kalscheuer; Inge Liebaers; Maryse Bonduelle; Herman Tournaye; Carmen Ayuso; Gotthold Barbi; Elisabeth Blennow; Georges Bourrouillou; Karen Brøndum-Nielsen; Gert Bruun-Petersen; Marie-Françoise Croquette; Sophie Dahoun; Bruno Dallapiccola; Val Davison; Bruno Delobel; Hans-Christoph Duba; Laurence Duprez; Malcolm A. Ferguson-Smith; David Fitzpatrick; Elizabeth Grace

In a search for potential infertility loci, which might be revealed by clustering of chromosomal breakpoints, we compiled 464 infertile males with a balanced rearrangement from Mendelian Cytogenetics Network database (MCNdb) and compared their karyotypes with those of a Danish nation-wide cohort. We excluded Robertsonian translocations, rearrangements involving sex chromosomes and common variants. We identified 10 autosomal bands, five of which were on chromosome 1, with a large excess of breakpoints in the infertility group. Some of these could potentially harbour a male-specific infertility locus. However, a general excess of breakpoints almost everywhere on chromosome 1 was observed among the infertile males: 26.5 versus 14.5% in the cohort. This excess was observed both for translocation and inversion carriers, especially pericentric inversions, both for published and unpublished cases, and was significantly associated with azoospermia. The largest number of breakpoints was reported in 1q21; FISH mapping of four of these breakpoints revealed that they did not involve the same region at the molecular level. We suggest that chromosome 1 harbours a critical domain whose integrity is essential for male fertility.


American Journal of Human Genetics | 2013

Enhanced Maternal Origin of the 22q11.2 Deletion in Velocardiofacial and DiGeorge Syndromes

Maria Delio; Tingwei Guo; Donna M. McDonald-McGinn; Elaine H. Zackai; Sean B. Herman; Mark Kaminetzky; Anne Marie Higgins; Karlene Coleman; Carolyn Chow; Maria Jarlbrzkowski; Carrie E. Bearden; Alice Bailey; Anders Vangkilde; Line Olsen; Charlotte Olesen; Flemming Skovby; Thomas Werge; Ludivine Templin; Tiffany Busa; Nicole Philip; Ann Swillen; Joris Vermeesch; Koen Devriendt; Maude Schneider; Sophie Dahoun; Stephan Eliez; Kelly Schoch; Stephen R. Hooper; Vandana Shashi; Joy Samanich

Velocardiofacial and DiGeorge syndromes, also known as 22q11.2 deletion syndrome (22q11DS), are congenital-anomaly disorders caused by a de novo hemizygous 22q11.2 deletion mediated by meiotic nonallelic homologous recombination events between low-copy repeats, also known as segmental duplications. Although previous studies exist, each was of small size, and it remains to be determined whether there are parent-of-origin biases for the de novo 22q11.2 deletion. To address this question, we genotyped a total of 389 DNA samples from 22q11DS-affected families. A total of 219 (56%) individuals with 22q11DS had maternal origin and 170 (44%) had paternal origin of the de novo deletion, which represents a statistically significant bias for maternal origin (p = 0.0151). Combined with many smaller, previous studies, 465 (57%) individuals had maternal origin and 345 (43%) had paternal origin, amounting to a ratio of 1.35 or a 35% increase in maternal compared to paternal origin (p = 0.000028). Among 1,892 probands with the de novo 22q11.2 deletion, the average maternal age at time of conception was 29.5, and this is similar to data for the general population in individual countries. Of interest, the female recombination rate in the 22q11.2 region was about 1.6-1.7 times greater than that for males, suggesting that for this region in the genome, enhanced meiotic recombination rates, as well as other as-of-yet undefined 22q11.2-specific features, could be responsible for the observed excess in maternal origin.


Journal of Immunology | 2006

Mechanisms Regulating the Proliferative Potential of Human CD8+ T Lymphocytes Overexpressing Telomerase

Olivier Menzel; Marco Migliaccio; Darlene R. Goldstein; Sophie Dahoun; Mauro Delorenzi; Nathalie Rufer

In human somatic cells, including T lymphocytes, telomeres progressively shorten with each cell division, eventually leading to a state of cellular senescence. Ectopic expression of telomerase results in the extension of their replicative life spans without inducing changes associated with transformation. However, it is yet unknown whether somatic cells that overexpress telomerase are physiologically indistinguishable from normal cells. Using CD8+ T lymphocyte clones overexpressing telomerase, we investigated the molecular mechanisms that regulate T cell proliferation. In this study, we show that early passage T cell clones transduced or not with human telomerase reverse transcriptase displayed identical growth rates upon mitogenic stimulation and no marked global changes in gene expression. Surprisingly, reduced proliferative responses were observed in human telomerase reverse transcriptase-transduced cells with extended life spans. These cells, despite maintaining high expression levels of genes involved in the cell cycle progression, also showed increased expression in several genes found in common with normal aging T lymphocytes. Strikingly, late passage T cells overexpressing telomerase accumulated the cyclin-dependent inhibitors p16Ink4a and p21Cip1 that have largely been associated with in vitro growth arrest. We conclude that alternative growth arrest mechanisms such as those mediated by p16Ink4a and p21Cip1 still remained intact and regulated the growth potential of cells independently of their telomere status.


European Journal of Medical Genetics | 2011

Initiation of a medical genetics service in sub-Saharan Africa: experience of prenatal diagnosis in Cameroon.

Ambroise Wonkam; Cedrik Ngongang Tekendo; Dohbit Julius Sama; Huguette Zambo; Sophie Dahoun; Frédérique Béna; Michael A. Morris

BACKGROUND Initiation of Prenatal Genetic Diagnosis (PND) has laid the foundation of the first medical genetic service in Cameroon. METHOD Cross-sectional descriptive study, illustrating some aspects of the genetic service using a small 24-months PND experience. RESULTS The service began with a medical geneticist who had to follow-up the building and equipments supplies of the diagnosis laboratory; and to personally perform genetic consultations, molecular experiments and post-results counseling. PND was indicated for sickle cell disease (SCD) in 33 cases (55%) and chromosomal anomalies in 27 cases (45%). With international collaboration, DNA analysis revealed 6 SCD-affected foetuses (20.7%); QF-PCR (N=25) and full karyotype (N=8) analysis revealed cases of trisomy 21 and trisomy 18. Following PND success, national effort granted more human and material resources to improve the service. The preliminary experience was made possible by three factors: 1) the availability of a trained Cameroonian medical geneticist 2) the availability of obstetricians trained in fetal medicine and 3) advocacy initiatives at national and international levels, which have proven invaluable for advice, training, sourcing of materials, and back-up reference diagnostic laboratory. CONCLUSION The practice of medical genetics, involving prenatal genetic diagnosis of sickle cell disease and chromosomal anomalies, is possible in Cameroon (sub-Saharan Africa).


American Journal of Medical Genetics Part A | 2008

Subtelomeric 6p deletion: Clinical and array-CGH characterization in two patients†

Danielle Martinet; Isabel Filges; Nathalie Besuchet Schmutz; Michael A. Morris; Anne-Claude Gaide; Sophie Dahoun; Armand Bottani; Marie-Claude Addor; Jacques S. Beckmann; Frédérique Béna

We report on two patients with de novo subtelomeric terminal deletion of chromosome 6p. Patient 1 is an 8‐month‐old female born with normal growth parameters, typical facial features of 6pter deletion, bilateral corectopia, and protruding tongue. She has severe developmental delay, profound bilateral neurosensory deafness, poor visual contact, and hypsarrhythmia since the age of 6 months. Patient 2 is a 5‐year‐old male born with normal growth parameters and unilateral hip dysplasia; he has a characteristic facial phenotype, bilateral embryotoxon, and moderate mental retardation. Further characterization of the deletion, using high‐resolution array comparative genomic hybridization (array‐CGH; Agilent Human Genome kit 244 K), revealed that Patient 1 has a 8.1 Mb 6pter‐6p24.3 deletion associated with a contiguous 5.8 Mb 6p24.3‐6p24.1 duplication and Patient 2 a 5.7 Mb 6pter‐6p25.1 deletion partially overlapping with that of Patient 1. Complementary FISH and array analysis showed that the inv del dup(6) in Patient 1 originated de novo. Our results demonstrate that simple rearrangements are often more complex than defined by standard techniques. We also discuss genotype–phenotype correlations including previously reported cases of deletion 6p.


Clinical Genetics | 2001

Familial t(6;21)(p21.1;p13) translocation associated with male-only sterility

Ariane Paoloni-Giacobino; I Kern; Y Rumpler; R Djlelati; Michael A. Morris; Sophie Dahoun

A 38‐year‐old male with primary infertility was referred for cytogenetic investigation. Karyotype analysis revealed a 46,XY,t(6;21)(p21.1;p13) translocation. The Ag‐nucleolar organizer regions (NORs) banding technique demonstrated that the 21p NORs were retained in the derivative and actively transcribed. Family studies showed that three brothers, two sisters and their mother carried the t(6;21). All carrier males suffered from primary infertility with severe oligoasthenoteratospermia or azoospermia, whereas at least two of the three carrier women were fertile. The region of the translocation breakpoint was narrowed down cytogenetically and by fluorescence in situ hybridisation as 21p13 and 6p21.1. Southern blot analysis showed that the gene ZNF165, which maps to this region and which is specifically expressed in the testis, was not disrupted by the translocation. However, studies performed on testicular biopsy showed spermatocyte meiosis anomalies. We discuss the possible mechanisms by which the translocation might affect meiosis in spermatogenesis and lead to infertility.


American Journal of Medical Genetics Part A | 2008

Monozygotic twins discordant for trisomy 21 and maternal 21q inheritance: a complex series of events

Sophie Dahoun; Sarantis Gagos; Maryline Gagnebin; Corinne Gehrig; Carole Burgi; Fabienne Simon; Chantal Vieux; Philippe Extermann; Robert Lyle; Michael A. Morris; Frédérique Béna; Jean-Louis Blouin

We report on a monochorionic/diamniotic twin pregnancy discordant for trisomy 21. Amniocentesis (at

Collaboration


Dive into the Sophie Dahoun's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert Lyle

Oslo University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge